{"data":[{"accessionNo":"0001274173-26-000205","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001359931","issuerName":"PROTARA THERAPEUTICS, INC.","ticker":"TARA","cusip":"74365U107","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"JANUS HENDERSON GROUP Ltd.","reportingCik":null,"personType":"HC","sharesOwned":4696709,"percentOfClass":8.4,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/tara"},{"accessionNo":"0001104659-26-081389","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001359931","issuerName":"Protara Therapeutics, Inc.","ticker":"TARA","cusip":"74365U107","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-01","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":3201936,"percentOfClass":5.7,"filedAt":"2026-07-07","canonicalUrl":"https://xoomar.com/markets/stocks/tara"},{"accessionNo":"0001104659-26-081389","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001359931","issuerName":"Protara Therapeutics, Inc.","ticker":"TARA","cusip":"74365U107","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-01","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":3201936,"percentOfClass":5.7,"filedAt":"2026-07-07","canonicalUrl":"https://xoomar.com/markets/stocks/tara"},{"accessionNo":"0001104659-26-081389","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001359931","issuerName":"Protara Therapeutics, Inc.","ticker":"TARA","cusip":"74365U107","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-01","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":3201936,"percentOfClass":5.7,"filedAt":"2026-07-07","canonicalUrl":"https://xoomar.com/markets/stocks/tara"},{"accessionNo":"0001104659-26-081389","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001359931","issuerName":"Protara Therapeutics, Inc.","ticker":"TARA","cusip":"74365U107","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-01","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":2879674,"percentOfClass":5.1,"filedAt":"2026-07-07","canonicalUrl":"https://xoomar.com/markets/stocks/tara"},{"accessionNo":"0001274173-26-000151","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001359931","issuerName":"PROTARA THERAPEUTICS, INC.","ticker":"TARA","cusip":"74365U107","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":5207011,"percentOfClass":9.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tara"},{"accessionNo":"0002012383-26-001712","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001359931","issuerName":"Protara Therapeutics, Inc.","ticker":"TARA","cusip":"74365U107","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":3387459,"percentOfClass":6.3,"filedAt":"2026-04-27","canonicalUrl":"https://xoomar.com/markets/stocks/tara"},{"accessionNo":"0001104659-26-022274","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001359931","issuerName":"Protara Therapeutics, Inc.","ticker":"TARA","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-02-25","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":2759231,"percentOfClass":5.1,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/tara"},{"accessionNo":"0001104659-26-022274","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001359931","issuerName":"Protara Therapeutics, Inc.","ticker":"TARA","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-02-25","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":2759231,"percentOfClass":5.1,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/tara"},{"accessionNo":"0001104659-26-022274","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001359931","issuerName":"Protara Therapeutics, Inc.","ticker":"TARA","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-02-25","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":2759231,"percentOfClass":5.1,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/tara"},{"accessionNo":"0001274173-26-000085","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001359931","issuerName":"PROTARA THERAPEUTICS, INC.","ticker":"TARA","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":5141616,"percentOfClass":10,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/tara"},{"accessionNo":"0002012383-26-000705","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001359931","issuerName":"Protara Therapeutics, Inc.","ticker":"TARA","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":2408868,"percentOfClass":4.7,"filedAt":"2026-01-21","canonicalUrl":"https://xoomar.com/markets/stocks/tara"},{"accessionNo":"0001274173-25-000287","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001359931","issuerName":"PROTARA THERAPEUTICS, INC.","ticker":"TARA","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":4231331,"percentOfClass":11,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/tara"},{"accessionNo":"0001274173-25-000287","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001359931","issuerName":"PROTARA THERAPEUTICS, INC.","ticker":"TARA","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Janus Henderson Biotech Innovation Master Fund Ltd","reportingCik":null,"personType":"IV","sharesOwned":3579068,"percentOfClass":9.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/tara"}],"updatedAt":"2026-11-04T03:51:29.007Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/tara","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}